Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis

BACKGROUND: Systemic juvenile idiopathic arthritis (SoJIA) is the most striking form of juvenile idiopathic arthritis. The aim of our study was to evaluate the clinical responses and outcomes of children with SoJIA to IL-6 blockade using two different tocilizumab (TCZ) treatment protocols designed f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatr Rheumatol Online J
Hauptverfasser: Kostik, Mikhail M, Dubko, Margarita F, Masalova, Vera V, Snegireva, Ludmila S, Kornishina, Tatyana L, Chikova, Irina A, Isupova, Eugenia A, Kuchinskaya, Ekaterina M, Glebova, Natalia I, Buchinskaya, Natalia V, Kalashnikova, Olga V, Chasnyk, Vyacheslav G
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2015
Schlagworte:
Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4328569/
https://ncbi.nlm.nih.gov/pubmed/25685108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1546-0096-13-4
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge